Drug delivery systems for potential treatment of intracellular bacterial infections.
Despite the advent of a considerable number of new antibiotics, treatment of intracellular pathogens still represents a major pharmaceutical challenge. The antibiotic concentration in those specialized niches are often subtherapeutic, for which high doses of antibiotics must often be used. This is n...
Main Authors: | Imbuluzqueta, E. (Edurne), Gamazo, C. (Carlos), Ariza, J. (J.), Blanco-Prieto, M.J. (María José) |
---|---|
Format: | info:eu-repo/semantics/article |
Language: | eng |
Published: |
Frontiers in Bioscience
2012
|
Subjects: | |
Online Access: | https://hdl.handle.net/10171/22391 |
Similar Items
-
Novel bioactive hydrophobic gentamicin carriers for the treatment of intracellular bacterial infections.
by: Imbuluzqueta, E. (Edurne), et al.
Published: (2011) -
Intracellular killing of Brucella melitensis in human macrophages with microspheres-encapsulated gentamicin
by: Lecaroz, M.C. (María Concepción), et al.
Published: (2010) -
Cellular pharmacokinetics and intracellular activity against Listeria monocytogenes and Staphylococcus aureus of chemically modified and nanoencapsulated gentamicin
by: Imbuluzqueta, E. (Edurne), et al.
Published: (2013) -
Design and development of novel cyclosporine A lipid nanoparticle formulations appropriate for oral delivery
by: Guada, M. (Melissa), et al.
Published: (2016) -
Nanomedicines for Pediatric Cancers
by: Rodriguez-Nogales, C. (Carlos), et al.
Published: (2024)